Valuation: Phaarmasia Limited

Market Cap 609M 6.35M 5.5M 5.2M 4.72M 8.85M 8.9M 62.11M 24M 309M 23.86M 23.33M 985M P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 512M 5.34M 4.63M 4.37M 3.97M 7.44M 7.49M 52.22M 20.18M 260M 20.06M 19.62M 828M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 day-1.40%
Current month-12.02%
1 month+14.84%
3 months-11.78%
6 months+2.98%
Current year-21.94%
1 week 85
Extreme 85
90
1 month 67
Extreme 67
104.95
Current year 67
Extreme 67
131.75
1 year 30.01
Extreme 30.01
131.75
3 years 23.51
Extreme 23.51
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 11/02/2016
Compliance Officer - 02/01/2020
Director TitleAgeSince
Chairman 71 13/10/2010
Director/Board Member 55 08/12/2012
Director/Board Member 63 18/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%0.00%+120.55%+222.34% 6.35M
+0.15%+1.21%+48.79%+97.65% 1,014B
+0.03%+0.07%+51.47%+65.55% 644B
-0.20%+4.62%+21.39%+72.57% 464B
-0.72%+4.26%+40.29%+38.70% 354B
+0.88%+2.35%+17.96%+23.87% 265B
+1.20%+4.17%+6.96%+10.93% 253B
+0.19%-3.81%+37.81%+44.35% 203B
+0.84%-5.64%-24.09%-59.10% 186B
+0.94%+1.39%+33.21%+95.16% 183B
Average +0.19%+1.00%+35.43%+61.20% 356.68B
Weighted average by Cap. +0.20%+1.41%+34.38%+59.76%

Financials

2025 2026
Net sales 244M 2.54M 2.2M 2.08M 1.89M 3.54M 3.56M 24.84M 9.6M 124M 9.54M 9.33M 394M 472M 4.92M 4.26M 4.03M 3.66M 6.86M 6.9M 48.12M 18.59M 239M 18.49M 18.08M 763M
Net income -15.89M -166K -144K -136K -123K -231K -232K -1.62M -626K -8.06M -622K -609K -25.7M 176M 1.83M 1.59M 1.5M 1.36M 2.55M 2.57M 17.91M 6.92M 89.13M 6.88M 6.73M 284M
Net Debt -1.94M -20.19K -17.5K -16.54K -15.01K -28.14K -28.31K -197K -76.29K -982K -75.85K -74.16K -3.13M -96.98M -1.01M -876K -828K -752K -1.41M -1.42M -9.88M -3.82M -49.19M -3.8M -3.71M -157M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
17/09/26 88.00 -1.40% 299
16/09/26 ₹89.25 +5.00% 202
15/09/26 ₹85.00 -1.39% 876
11/09/26 ₹86.20 -2.05% 163
10/09/26 ₹88.00 0.00% 852
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!